(Q44859078)

6 December 2017

Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans (English)

1 reference

6 December 2017

1

1 reference

6 December 2017

Bart Marescau

2

1 reference

6 December 2017

Els Vanden Eede

3

1 reference

6 December 2017

Bert O Eijnde

4

1 reference

6 December 2017

Peter P De Deyn

5

1 reference

6 December 2017

Peter Hespel

6

1 reference

6 December 2017

language of work or name

English

0 references

publication date

23 April 2004

1 reference

Journal of Applied Physiology

6 December 2017

1 reference

6 December 2017

97

1 reference

6 December 2017

3

1 reference

6 December 2017

852-857

1 reference

Inhibition of arginine synthesis by urea: a mechanism for arginine deficiency in renal failure which leads to increased hydroxyl radical generation

6 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Endogenous guanidino compounds as uremic neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Guanidino compound levels in brain regions of non-dialyzed uremic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Creatine supplementation in health and disease: what is the evidence for long-term efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Muscle creatine loading in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Guanidino Compound Analysis as a Complementary Diagnostic Parameter for Hyperargininemia: Follow-Up of Guanidino Compound Levels during Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

The biosynthesis of guanidinosuccinic acid by perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Adverse effects of creatine supplementation: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Creatine deficiency syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

American College of Sports Medicine roundtable. The physiological and health effects of oral creatine supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Creatine and creatinine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00206.2004

10.1152/JAPPLPHYSIOL.00206.2004

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference